Lisha Jean Coster, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 165 Main St, Open Door Family Medical Centers, Inc., Ossining, NY 10562 Phone: 914-941-1263 Fax: 914-941-0993 |
Christina Marie Mannion, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 165 Main St, Open Door Family Medical Centers, Inc., Ossining, NY 10562 Phone: 914-941-1263 Fax: 914-941-0993 |
Sheila Townsend, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 165 Main St, Open Door Family Medical Centers, Inc., Ossining, NY 10562 Phone: 914-941-1263 Fax: 914-941-0993 |
Judith Mccarthy Dalton, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 165 Main St, Open Door Family Medical Centers, Inc., Ossining, NY 10562 Phone: 914-941-1263 Fax: 914-941-0993 |
News Archive
Mylan Laboratories Inc. has announced that the U.S. Food and Drug Administration has granted tentative approval for Mylan Pharmaceuticals Inc.'s Abbreviated New Drug Application for Rabeprazole Sodium Delayed-release Tablets, 20 mg.
Seeking to maximise the value of computational modelling in avoiding animal testing for the European Union's Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), the People for the Ethical Treatment of Animals (PETA) Foundation has produced a free resource for chemical companies, identifying sources of information and expertise on the use of Quantitative Structure Activity Relationships (QSARs).
Influenza immunization rates in children with inflammatory bowel disease (IBD) are low despite its safety according to a new study by researchers at the Institute for Clinical Evaluative Sciences (ICES), Children's Hospital of Eastern Ontario (CHEO), the Ottawa Hospital Research Institute (OHRI), and the University of Ottawa.
In a new study posted to the medRxiv* server scientists from Weil Cornell University and Stony Brook University in New York attempted to identify the metabolic and immune markers associated with severe COVID-19 disease using high-throughput targeted nuclear magnetic resonance (NMR) spectroscopy and high-dimensional flow cytometry. This will facilitate risk stratification, monitoring, and therapeutic interventions in COVID-19 patients.
› Verified 7 days ago